Cerecin

Cerecin is a global healthcare company founded in 2001 and headquartered in Singapore. The company, with its slogan "Cerecin is a healthcare company with almost 20 years of innovation and leadership in brain health," has almost two decades of experience in the biotechnology and healthcare industries. Cerecin's innovative approach focuses on developing evidence-based solutions including pharmaceuticals, medical foods, diagnostics, medical devices, and e-health products tailored to address a wide range of brain health issues, from memory impairment to severe neurological diseases. In the latest funding round, Series B investment at 28 September 2022, Cerecin secured investments from SK Securities and K&T partners. This demonstrates the confidence of prominent investors in the company's vision and potential. With its strong track record and expertise, Cerecin is poised to make significant strides in the global healthcare and biotechnology sectors.